Cargando…

Comparison of Bone Marrow Aspirate Concentrate and Allogenic Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Implantation on Chondral Defect of Knee: Assessment of Clinical and Magnetic Resonance Imaging Outcomes at 2-Year Follow-Up

Biological repair of cartilage lesions remains a significant clinical challenge. A wide variety of methods involving mesenchymal stem cells (MSCs) have been introduced. Because of the limitation of the results, most of the treatment methods have not yet been approved by the Food and Drug Administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Dong Jin, Jeon, Yoon Sang, Park, Jun Sung, Bae, Gi Cheol, Kim, Jeong-seok, Kim, Myung Ku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563925/
https://www.ncbi.nlm.nih.gov/pubmed/32713192
http://dx.doi.org/10.1177/0963689720943581
_version_ 1783595597921517568
author Ryu, Dong Jin
Jeon, Yoon Sang
Park, Jun Sung
Bae, Gi Cheol
Kim, Jeong-seok
Kim, Myung Ku
author_facet Ryu, Dong Jin
Jeon, Yoon Sang
Park, Jun Sung
Bae, Gi Cheol
Kim, Jeong-seok
Kim, Myung Ku
author_sort Ryu, Dong Jin
collection PubMed
description Biological repair of cartilage lesions remains a significant clinical challenge. A wide variety of methods involving mesenchymal stem cells (MSCs) have been introduced. Because of the limitation of the results, most of the treatment methods have not yet been approved by the Food and Drug Administration (FDA). However, bone marrow aspirate concentrate (BMAC) and human umbilical cord blood derived mesenchymal stem cells (hUCB-MSCs) implantation were approved by Korea FDA. The aim of this study was to evaluate clinical and magnetic resonance imaging (MRI) outcomes after two different types of MSCs implantation in knee osteoarthritis. Fifty-two patients (52 knees) who underwent cartilage repair surgery using the BMAC (25 knees) and hUCB-MSCs (27 knees) were retrospectively evaluated for 2 years after surgery. Clinical outcomes were evaluated according to the score of visual analogue scale (VAS), the International Knee Documentation Committee (IKDC) subjective, and the Knee Injury and Osteoarthritis Outcome Score (KOOS). Cartilage repair was assessed according to the modified Magnetic Resonance Observation of Cartilage Repair Tissue (M-MOCART) score and the International Cartilage Repair Society (ICRS) cartilage repair scoring system. At 2-year follow-up, clinical outcomes including VAS, IKDC, and KOOS significantly improved (P < 0.05) in both groups; however, there were no differences between two groups. There was no significant difference in M-MOCART [1-year (P = 0.261), 2-year (P = 0.351)] and ICRS repair score (P = 0.655) between two groups. Both groups showed satisfactory clinical and MRI outcomes. Implantation of MSCs from BMAC or hUCB-MSCs is safe and effective for repairing cartilage lesion. However, large cases and a well-controlled prospective design with long-term follow-up studies are needed.
format Online
Article
Text
id pubmed-7563925
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-75639252020-10-26 Comparison of Bone Marrow Aspirate Concentrate and Allogenic Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Implantation on Chondral Defect of Knee: Assessment of Clinical and Magnetic Resonance Imaging Outcomes at 2-Year Follow-Up Ryu, Dong Jin Jeon, Yoon Sang Park, Jun Sung Bae, Gi Cheol Kim, Jeong-seok Kim, Myung Ku Cell Transplant Original Article Biological repair of cartilage lesions remains a significant clinical challenge. A wide variety of methods involving mesenchymal stem cells (MSCs) have been introduced. Because of the limitation of the results, most of the treatment methods have not yet been approved by the Food and Drug Administration (FDA). However, bone marrow aspirate concentrate (BMAC) and human umbilical cord blood derived mesenchymal stem cells (hUCB-MSCs) implantation were approved by Korea FDA. The aim of this study was to evaluate clinical and magnetic resonance imaging (MRI) outcomes after two different types of MSCs implantation in knee osteoarthritis. Fifty-two patients (52 knees) who underwent cartilage repair surgery using the BMAC (25 knees) and hUCB-MSCs (27 knees) were retrospectively evaluated for 2 years after surgery. Clinical outcomes were evaluated according to the score of visual analogue scale (VAS), the International Knee Documentation Committee (IKDC) subjective, and the Knee Injury and Osteoarthritis Outcome Score (KOOS). Cartilage repair was assessed according to the modified Magnetic Resonance Observation of Cartilage Repair Tissue (M-MOCART) score and the International Cartilage Repair Society (ICRS) cartilage repair scoring system. At 2-year follow-up, clinical outcomes including VAS, IKDC, and KOOS significantly improved (P < 0.05) in both groups; however, there were no differences between two groups. There was no significant difference in M-MOCART [1-year (P = 0.261), 2-year (P = 0.351)] and ICRS repair score (P = 0.655) between two groups. Both groups showed satisfactory clinical and MRI outcomes. Implantation of MSCs from BMAC or hUCB-MSCs is safe and effective for repairing cartilage lesion. However, large cases and a well-controlled prospective design with long-term follow-up studies are needed. SAGE Publications 2020-07-27 /pmc/articles/PMC7563925/ /pubmed/32713192 http://dx.doi.org/10.1177/0963689720943581 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Ryu, Dong Jin
Jeon, Yoon Sang
Park, Jun Sung
Bae, Gi Cheol
Kim, Jeong-seok
Kim, Myung Ku
Comparison of Bone Marrow Aspirate Concentrate and Allogenic Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Implantation on Chondral Defect of Knee: Assessment of Clinical and Magnetic Resonance Imaging Outcomes at 2-Year Follow-Up
title Comparison of Bone Marrow Aspirate Concentrate and Allogenic Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Implantation on Chondral Defect of Knee: Assessment of Clinical and Magnetic Resonance Imaging Outcomes at 2-Year Follow-Up
title_full Comparison of Bone Marrow Aspirate Concentrate and Allogenic Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Implantation on Chondral Defect of Knee: Assessment of Clinical and Magnetic Resonance Imaging Outcomes at 2-Year Follow-Up
title_fullStr Comparison of Bone Marrow Aspirate Concentrate and Allogenic Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Implantation on Chondral Defect of Knee: Assessment of Clinical and Magnetic Resonance Imaging Outcomes at 2-Year Follow-Up
title_full_unstemmed Comparison of Bone Marrow Aspirate Concentrate and Allogenic Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Implantation on Chondral Defect of Knee: Assessment of Clinical and Magnetic Resonance Imaging Outcomes at 2-Year Follow-Up
title_short Comparison of Bone Marrow Aspirate Concentrate and Allogenic Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Implantation on Chondral Defect of Knee: Assessment of Clinical and Magnetic Resonance Imaging Outcomes at 2-Year Follow-Up
title_sort comparison of bone marrow aspirate concentrate and allogenic human umbilical cord blood derived mesenchymal stem cell implantation on chondral defect of knee: assessment of clinical and magnetic resonance imaging outcomes at 2-year follow-up
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563925/
https://www.ncbi.nlm.nih.gov/pubmed/32713192
http://dx.doi.org/10.1177/0963689720943581
work_keys_str_mv AT ryudongjin comparisonofbonemarrowaspirateconcentrateandallogenichumanumbilicalcordbloodderivedmesenchymalstemcellimplantationonchondraldefectofkneeassessmentofclinicalandmagneticresonanceimagingoutcomesat2yearfollowup
AT jeonyoonsang comparisonofbonemarrowaspirateconcentrateandallogenichumanumbilicalcordbloodderivedmesenchymalstemcellimplantationonchondraldefectofkneeassessmentofclinicalandmagneticresonanceimagingoutcomesat2yearfollowup
AT parkjunsung comparisonofbonemarrowaspirateconcentrateandallogenichumanumbilicalcordbloodderivedmesenchymalstemcellimplantationonchondraldefectofkneeassessmentofclinicalandmagneticresonanceimagingoutcomesat2yearfollowup
AT baegicheol comparisonofbonemarrowaspirateconcentrateandallogenichumanumbilicalcordbloodderivedmesenchymalstemcellimplantationonchondraldefectofkneeassessmentofclinicalandmagneticresonanceimagingoutcomesat2yearfollowup
AT kimjeongseok comparisonofbonemarrowaspirateconcentrateandallogenichumanumbilicalcordbloodderivedmesenchymalstemcellimplantationonchondraldefectofkneeassessmentofclinicalandmagneticresonanceimagingoutcomesat2yearfollowup
AT kimmyungku comparisonofbonemarrowaspirateconcentrateandallogenichumanumbilicalcordbloodderivedmesenchymalstemcellimplantationonchondraldefectofkneeassessmentofclinicalandmagneticresonanceimagingoutcomesat2yearfollowup